Health care looms large as deadline nears on One Big Beautiful Bill
WASHINGTON — With days to go before Congress is set to leave town, lawmakers are still at odds…
Google’s AI company DeepMind launches genetics prediction tool| STAT
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
GLP-1 drugs effective for type 1 diabetes in new study| STAT
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Amgen obesity drug MariTide led to high discontinuation rates in trial
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects…
Breyer Capital’s Morgan Cheatham on investing in health tech
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Employer health care costs stand in the way of reshoring American jobs
The Trump administration continues to pursue the most aggressive tariff policies since the Smoot-Hawley Tariff Act of 1930.…
Study finds GLP-1 drug cut migraine frequency by nearly half
GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency. That is…
FDA ouster of top gene therapy official reveals internal tensions
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…